US Corporate Board Director Changes SEC Filings — April 27, 2026

27-04-2026

On April 20, 2026, Suncrete, Inc. increased its Board of Directors from seven to nine members, appointing Charles Owens as a Class I director (term expiring 2027) and Noreen Skelly as a Class II director (term expiring 2028), both joining the Audit Committee with Skelly as Chair. Owens brings extensive construction industry experience as a founder and former CEO of Construction Partners, Inc. (ROAD), while Skelly offers deep financial expertise as CFO of Blue Sky Bank and former CFO roles at multiple banks. The Board also granted restricted stock awards totaling 528,000 shares (96,000 Class A, 432,000 Class B) to eight non-employee directors under the 2026 Omnibus Incentive Plan as board service compensation.

• ·Restricted stock vests two-thirds on second anniversary and one-third on third anniversary of April 20, 2026 grant date, subject to continued service.
• ·New directors determined independent under SEC and Nasdaq rules; no arrangements or material interests under Item 404(a) of Regulation S-K.
• ·Director Grants issued under Section 4(a)(2) and/or Regulation D exemption from Securities Act registration.

27-04-2026

On April 23, 2026, the Board of Directors of Miami International Holdings, Inc. elected Eric Sites as a director to fill an existing vacancy, effective April 24, 2026, until the 2026 Annual Meeting of Shareholders or until his successor is elected and qualified. Mr. Sites has not been appointed to any Board committees and will receive standard non-employee director compensation, with no family relationships, related transactions, or arrangements disclosed regarding his election. He has entered into a standard indemnification agreement with the Company.

27-04-2026

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) announced the appointment of Daniel B. Gilmer, Ph.D., a biopharmaceutical commercial executive and current Senior Director at Pfizer Inc., to its Board of Directors, effective April 24, 2026. Dr. Gilmer brings extensive experience in commercial launches, including leading the U.S. rollout of PAXLOVID and co-inventing Exebacase (CF-301/PlySs2), a bacteriophage lysin that received FDA Fast Track and Breakthrough Therapy designations. The appointment aims to bolster Armata's efforts to commercialize its pathogen-specific bacteriophage therapeutics for antibiotic-resistant infections.

• ·Dr. Gilmer joined Pfizer in May 2019; led U.S. PAXLOVID launch after FDA New Drug Approval.
• ·Previously at Pfizer: Antiviral and Diagnostics Business (Apr 2022-Feb 2025), Inflammation & Immunology (Apr 2021-Apr 2022).
• ·Ph.D. in Microbiology from Rockefeller University; B.S. from Howard University.
• ·Serves on Rockefeller University Board of Trustees Educational Affairs Committee and Ford Center Incubator selection committee.
• ·Member of New York Academy of Sciences and term member at Council on Foreign Relations.

27-04-2026

AIG announced the completion of its planned CEO transition plan, with Eric Andersen becoming President and Chief Executive Officer and joining the Board of Directors effective June 1, 2026, while Peter Zaffino transitions to Executive Chair of the AIG Board. Leadership changes were praised for positioning AIG as a global leader with strong momentum from prior transformations. Further commentary will be provided during AIG’s Q1 2026 earnings call on May 1, 2026.

• ·Eric Andersen joined AIG in February 2026 as President and CEO-Elect.
• ·Q1 2026 earnings conference call scheduled for May 1, 2026, at 8:30 a.m. ET, with live webcast and replay available on www.aig.com.
• ·AIG (NYSE: AIG) is a leading global insurance organization.

27-04-2026

Avient Corporation announced the resignation of Jamie A. Beggs as Senior Vice President and Chief Financial Officer, effective June 1, 2026, to pursue other professional opportunities, with no disagreements on company matters. The Board appointed internal executive Giuseppe (Joe) Di Salvo, age 48, as the new Senior Vice President and Chief Financial Officer effective the same date. Di Salvo's package includes a $560,000 annual base salary and a one-time $220,000 RSU grant vesting over three years.

• ·Resignation notified on April 22, 2026; appointment by Board on April 24, 2026.
• ·Di Salvo previously served as Corporate Controller (2013-2018), VP Investor Relations, and led Treasury and FP&A since 2019.
• ·Severance under Executive Severance Plan: two years salary continuation, pro-rated incentive, and benefits if terminated without cause (non-change in control).
• ·Change-in-control Continuity Agreement provides lump-sum severance of two years base salary and target incentive if terminated within 24 months post-change in control.

27-04-2026

Abbott Laboratories amended and restated its By-Laws, effective April 24, 2026, originally adopted in 1963. The updated By-Laws specify the principal office location in Lake County, Illinois, and outline procedures for annual shareholder meetings, including election of directors and transaction of business. They impose detailed and stringent requirements for shareholder nominations and proposals, mandating timely written notices 90-120 days prior to the anniversary of the prior annual meeting, with updates and supplements as needed.

• ·Principal office: intersection of State Routes 43 and 137, Lake County, Illinois.
• ·Shareholder notice timeliness: not later than 90th day nor earlier than 120th day prior to prior annual meeting anniversary; adjusted if meeting date shifts by more than 30-60 days.
• ·Notice updates required as of record date and 10 business days prior to meeting.
• ·References Exchange Act rules including Rule 14a-8, Schedule 13D, 13F, 13G.

27-04-2026

Columbia Financial, Inc. entered into new two-year employment agreements effective April 1, 2026, with five senior executives—Dennis E. Gibney, Allyson Schlesinger, John Klimowich, Oliver E. Lewis, Jr., and Manesh Prabhu—replacing prior agreements and including annual base salaries for 2026 ranging from $430,000 to $700,000, eligibility for incentive plans, equity awards, and fringe benefits. The agreements feature automatic annual extensions unless notice is given 60 days prior, post-employment restrictive covenants, and severance provisions including 2x (base salary + target bonus) for termination without cause, escalating to 3x upon a change in control. No performance declines or negative metrics are reported in this governance-focused filing.

• ·Agreements entered into on April 21-22, 2026; initial term two years with auto-extension by 12 months each April 1 starting 2027 unless 60-day notice.
• ·Severance for termination without cause: 2x (base salary + target bonus); for disability/death: 1x (base salary + target bonus).
• ·Change in control severance within 24 months: 3x (base salary + target bonus) plus prior year bonus and 36 months health coverage subsidy.
• ·Restrictive covenants: 24-month non-solicitation/non-competition, perpetual confidentiality, mutual non-disparagement.

27-04-2026

Patrick R. Gruber retired as Chief Executive Officer of Gevo, Inc. on April 1, 2026. On April 22, 2026, the company entered into a Consulting Services Agreement with Patrick Gruber LLC (owned by Dr. Gruber), effective May 1, 2026, under which the consultant will provide transitional services until March 31, 2029, for a monthly fee of $30,000. The agreement includes customary provisions on confidentiality, work product ownership, and indemnification, and is subject to earlier termination by the company for cause or upon Dr. Gruber's death.

• ·Consulting Agreement filed as Exhibit 10.1
• ·Agreement dated April 22, 2026, with effective date of May 1, 2026

27-04-2026

Stanley Black & Decker, Inc. held its 2026 Annual Meeting of Shareholders on April 24, 2026, where all 10 director nominees were elected with strong support (122.8M-124.8M For votes out of 155.3M outstanding shares). Shareholders approved the Amended and Restated 2024 Omnibus Award Plan (120.2M For), advisory say-on-pay (122.0M For), and Ernst & Young LLP as auditor (134.1M For). However, a shareholder proposal for an independent board chairman failed overwhelmingly (10.5M For vs. 114.5M Against).

• ·Record date for meeting: February 25, 2026
• ·Board approved Amended Plan on February 24, 2026
• ·Fungible ratio adjusted to 2.71 for awards after effectiveness
• ·One-year minimum vesting period added to Amended Plan, subject to exceptions

27-04-2026

Domino’s Pizza, Inc. appointed Brian J. Pangburn, age 41, as Vice President—Controller and principal accounting officer, effective April 21, 2026. Mr. Pangburn has been with the company since February 2008, most recently as Senior Director—Assistant Controller since June 2025. Jessica L. Parrish, the previous Vice President—Chief Accounting Officer and Treasurer, will cease serving as principal accounting officer but continue as a Vice President in a different finance leadership role.

• ·Mr. Pangburn's prior roles: Senior Director—Assistant Controller (June 2025), Senior Director—Accounting (October 2023 to June 2025), Director—Accounting (June 2020 to October 2023).
• ·Filing signed on April 27, 2026.

27-04-2026

On April 23, 2026, Xencor, Inc. adopted the Executive Severance Policy applicable to certain executives, including named executive officers (NEOs) except the CEO, who must sign a participation agreement to be eligible. Outside a Change in Control Period, eligible NEOs receive 15 months of base salary and up to 15 months of COBRA premiums upon termination without Cause or resignation for Good Reason, subject to a release. During a Change in Control Period, additional benefits include 15 months of target bonus, a prorated annual bonus, and accelerated vesting of all outstanding unvested equity awards.

• ·Change in Control Period defined as three months prior to and 12 months following a change in control.
• ·Policy filed as Exhibit 10.1.
• ·NEOs must execute a general release for benefits to apply.

27-04-2026

On April 22, 2026, Max Brodén, a member of Trupanion's Board of Directors, notified the company that he will not stand for re-election at the 2026 Annual Stockholders’ Meeting on June 10, 2026, citing personal reasons with no disagreements with the company or Board; he will serve until the meeting. His departure does not impact the strategic partnership with Aflac, which remains committed. Trupanion filed its 2025 Annual Report, including a Shareholder Letter, on April 27, 2026.

• ·2026 Annual Meeting scheduled at 9 am Pacific Time on June 10, 2026
• ·Item 7.01 information furnished under Regulation FD, not deemed 'filed' for liability purposes

27-04-2026

agilon health (NYSE: AGL) appointed Tim O’Rourke as Chief Executive Officer and Board member effective May 7, 2026, succeeding Ronald A. Williams, who transitions from Executive Chairman (since August 2025) to continue as Chairman of the Board. The move follows operational and financial transformation, positioning the company to capitalize on value-based care demand with O’Rourke's 25+ years of payor and provider experience. agilon operates a platform with a peer network of approximately 2,300 primary care physicians across 30 communities.

• ·O’Rourke's prior roles: President of Help at Home; CEO of Ascension Complete; 17 years at Humana in Medicare Advantage and value-based care
• ·Ronald A. Williams served as Executive Chairman since August 2025
• ·Investor contacts: Evan Smith (SVP, Investor Relations), Megan Cagle

27-04-2026

Charging Robotics Inc. announced the resignation of CEO Yakov Baranes effective May 1, 2026, for personal reasons with no disagreements on company matters; he will remain on the board. The company appointed Meni Nachmias, a senior executive with over 20 years of experience including roles in the Israeli Navy and Bullard Maritime Services, as the new CEO effective the same date. Nachmias' base salary is NIS 12,000 per month under an at-will agreement terminable with 30 days' notice.

• ·Nachmias holds MA in international relations and negotiation and BA in political science and human services from University of Haifa.
• ·No arrangement or understanding with other persons for Nachmias' appointment; no disclosable transactions under Item 404(a) of Regulation S-K.
• ·Company is an emerging growth company.

27-04-2026

Fossil Group, Inc. announced on April 24, 2026, that Joe Martin resigned as Chief Commercial Officer to pursue other interests, with his last day set for May 8, 2026. CEO Franco Fogliato will immediately assume Mr. Martin's responsibilities, leveraging his prior experience leading the commercial sales organization. The company has begun searching for a successor.

• ·The 8-K was filed on April 27, 2026.

27-04-2026

Booz Allen Hamilton announced senior leadership changes effective May 2026 to bolster its advanced technology position: Troy Lahr appointed EVP and CFO effective May 4, reporting to CEO Horacio Rozanski; Kristine Martin Anderson elevated to President alongside her COO role effective May 1; Shannon Fitzgerald promoted to President of Civil Sector; and Richard Crowe to Chief Growth Officer. These moves highlight internal promotions and external hires with deep experience in finance, operations, and growth. The company employs approximately 31,600 people globally as of December 31, 2025, with $12.0 billion in revenue for the 12 months ended March 31, 2025.

• ·Troy Lahr brings over 25 years of experience, most recently as CFO at Sierra Space and previously CFO of Boeing’s Defense, Space & Security business.
• ·Kristine Martin Anderson has been a leader at Booz Allen for 20 years, becoming COO in 2022 after leading the Civil Sector business.
• ·Lahr began career with over a decade in investment banking at Stifel as an aerospace and defense equity analyst.

27-04-2026

On April 27, 2026, CDT Equity Inc. appointed Ulrik Olsen as a director and member of the Audit, Compensation, and Nominating and Corporate Governance Committees, filling a board vacancy following Freda Lewis-Hall's immediate resignation as director, Board chairperson, and committee chair/member for family health reasons, with no disagreements noted. Chele Chiavacci Farley was appointed as the new Board chairperson and Nominating Committee chairperson, stepping down as Audit Committee chairperson, while Simon Fry was named Audit Committee chairperson. Mr. Olsen, an experienced property executive, brings expertise from roles at Scarborough Group Limited, OB Energy, and Gull New Zealand, and the Company holds a 20% stake in Sarborg Limited where he owns approximately 7.84%.

• ·Ulrik Olsen has been a director of Scarborough Group Limited since 2017, managing director of OB Energy since 2018, and Chief Operating Officer of Gull New Zealand from 2015 to 2017.
• ·Board determined Ulrik Olsen meets independence requirements under Nasdaq and SEC standards.
• ·Ulrik Olsen will participate in the Company’s non-employee director compensation program; no family relationships or arrangements influencing his appointment.
• ·Freda Lewis-Hall's resignation effective immediately and not due to any disagreement with Company operations, policies, or practices.

27-04-2026

NVIDIA Corporation announced that Donald Robertson, VP and Chief Accounting Officer, will retire effective May 4, 2026, and remain as VP, Finance until July 1, 2026. The company appointed Scott Gawel, age 55 and formerly Corporate VP and CAO at Intel Corporation, as the new VP and CAO effective May 4, 2026, with an annual base salary of $800,000 and new hire RSUs valued at $12,875,000 vesting over four years. There are no related arrangements, transactions under Item 404(a) of Regulation S-K, or family relationships with directors or executives.

• ·Scott Gawel's prior roles: Corporate VP and CAO at Intel (2022-2026); Senior VP and Corporate Controller at Oracle (2020-2022); Senior VP and Assistant Controller at Oracle (2017-2020); VP, Corporate Accounting at Oracle (2009-2017); Senior Director, Corporate Accounting at Oracle (2004-2009).
• ·RSUs governed by NVIDIA's Amended and Restated 2007 Equity Incentive Plan.
• ·Scott Gawel eligible for standard employee benefits and will enter into the company's standard indemnity agreement.

27-04-2026

T1 Energy Inc. announced the retirement of Chief Development Officer Einar Kilde effective April 22, 2026, with a separation agreement providing NOK 5.5 million severance paid in 12 installments, retention of 210,000 RSUs and options eligible to vest per the 2021 Equity Incentive Plan, and an expected 2025 bonus. On April 27, 2026, the company finalized employment terms for Chief Accounting Officer and Corporate Controller Tom Mahrer, including annual base salary, group bonus eligibility, equity awards, and customary benefits. No financial performance metrics were disclosed.

• ·Einar Kilde's options exercise period extended beyond the standard three-month post-employment period under the Plan.
• ·Tom Mahrer's appointment was previously disclosed in February 6, 2026 Form 8-K.
• ·Separation Agreement includes confidentiality, non-disparagement, and return of company property obligations.

27-04-2026

On April 22, 2026, the Compensation Committee of ParkerVision, Inc. approved modifications to outstanding nonqualified stock options held by CEO Jeffrey Parker (2,660,000 options) and CFO Cynthia French (870,550 options), extending the expiration date from August 7, 2026, to August 7, 2029, to preserve long-term incentive value. The options were awarded on August 7, 2019, at an exercise price of $0.171 per share and are fully vested. The company expects to record a one-time non-cash share-based compensation charge of approximately $360,000.

• ·Options awarded on August 7, 2019, with exercise price of $0.171 per share.
• ·No changes to exercise price, number of shares, vesting status, or other terms.
• ·Modification filed under Items 5.02(e) and 9.01 of Form 8-K on April 27, 2026.

27-04-2026

PACS Group, Inc. announced the planned retirement of co-founder and CFO Mark Hancock on June 30, 2026, who will transition to Vice Chairman of the Board; he will be succeeded by Carey P. Hendrickson as the new CFO. Under Hancock's leadership since 2013, the company grew from 2 facilities to 323 across 17 states, serving over 31,700 patients daily and achieving full-year 2025 revenue of $5.29 billion, up 29.3% YoY. The transition is framed positively with emphasis on Hancock's legacy and Hendrickson's extensive healthcare finance experience.

• ·Company founded in 2013 with 2 facilities in San Diego, CA.
• ·IPO on NYSE in April 2024.
• ·Hancock served as Interim CFO in September 2025.

27-04-2026

Matador Resources Company (NYSE: MTDR) announced leadership promotions effective April 21, 2026: Christopher P. Calvert to Executive Vice President and Chief Financial Officer from his prior role as EVP and COO, and Glenn W. Stetson to Executive Vice President and Chief Operating Officer from EVP – Production. Robert T. Macalik ceased serving as CFO on the same date, with no relation to financial, accounting issues, or disagreements with the company. The promotions are intended to strengthen focus on execution, efficiency, and long-term value creation, with both promotees having over 10 years at Matador and approximately 20 years of industry experience.

• ·Calvert joined Matador in October 2014
• ·Stetson joined Matador in August 2014
• ·Both served on Matador’s Executive Committee
• ·Operations focused on Wolfcamp and Bone Spring plays in Delaware Basin, Haynesville shale and Cotton Valley plays in Northwest Louisiana

27-04-2026

On April 27, 2026, Splash Beverage Group, Inc. appointed Francis Knuettel II as a new director to its Board, effective immediately. Mr. Knuettel, experienced in CXO roles at early-stage public companies such as Pelthos Therapeutics Inc. (NYSE American: PTHS) and Unrivaled Brands, was also appointed to the Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee. There are no arrangements, family relationships, or disclosable transactions under Item 404(a) of Regulation S-K related to his appointment.

• ·Mr. Knuettel served as CFO of Pelthos Therapeutics Inc. from June 2022 to April 2026, CEO from July 2023 to July 2025, and director from August 2024 to July 2025.
• ·Prior to Pelthos, Mr. Knuettel was CEO and director of Unrivaled Brands from December 2020 to March 2022.

27-04-2026

LSB Industries, Inc.'s Compensation Committee approved a one-time retention grant of 706,880 restricted stock units (RSUs) to Chairman, President, and CEO Mark T. Behrman on April 24, 2026, under the 2025 Long-Term Incentive Plan, vesting on March 31, 2029, subject to continued service. The award includes dividend equivalents and accelerated vesting provisions for certain terminations like qualifying separation, death, or disability, but forfeiture in specific change-of-control scenarios. It aims to align executive interests with shareholders and incentivize company growth.

• ·RSUs represent right to one share of common stock or cash equivalent upon vesting.
• ·Full vesting acceleration on Qualifying Separation from Service (not in connection with change in control).
• ·Pro-rata vesting on death or disability prior to change in control.
• ·Forfeiture if Qualifying Separation occurs with change in control triggering employment agreement benefits.

27-04-2026

Meridian Corporation (NASDAQ: MRBK) announced the appointment of Ken Warriner to its Board of Directors and the board of its principal subsidiary, Meridian Bank, effective immediately on April 27, 2026. Warriner, Senior Director of Finance and Administration at the Naples Airport Authority since 2018, brings 16 years of healthcare finance experience and prior public accounting at PricewaterhouseCoopers, along with service on Meridian’s Advisory Council since 2022. Chairman Christopher J. Annas praised Warriner’s financial leadership, operational oversight, and strategic planning expertise as assets for delivering long-term shareholder value.

• ·Warriner began aviation career at Naples Airport Authority in 2018 and oversees accounting, IT, procurement, risk management, and investments
• ·Prior to NAA, 16 years in healthcare as Assistant Corporate Controller and CFO for hospitals in Florida and Mississippi
• ·Licensed Certified Public Accountant with degree from Baylor University
• ·Meridian Bank serves Pennsylvania, New Jersey, Delaware, Maryland, and Florida with business lending, real estate lending, electronic payments, and wealth management

27-04-2026

Sallie Mae (Nasdaq: SLM), formally SLM Corporation, announced the appointment of Chief Financial Officer Peter Graham and Chief Operational Officer Kerri Palmer as Co-Presidents, reporting to CEO Jon Witter, following the retirement of the Chief Commercial Officer. Graham will continue as CFO while overseeing strategic partnerships and emerging lines of business; Palmer will lead as Head of Financial Services, including the core private education loan business, credit, and operations. The appointments reflect the company's commitment to leadership depth and execution of its disciplined growth strategy amid strong performance.

• ·Graham has served as Executive Vice President and CFO since 2023, overseeing finance, accounting, treasury, and investor relations.
• ·Palmer has served as Executive Vice President, COO, and President of Sallie Mae Bank since 2023; previously Chief Risk Officer and Chief Risk and Compliance Officer.
• ·Appointments effective as of April 27, 2026 announcement.

27-04-2026

Guardant Health, Inc. announced the resignation of Craig Eagle, M.D., its Chief Medical Officer, effective May 8, 2026, as reported in this 8-K filing dated April 27, 2026. No reason for the departure was provided, and no successor was named. The filing was signed by John G. Saia, Chief Legal Officer and Corporate Secretary.

27-04-2026

Crane Company (NYSE: CR) announced the completion of its previously disclosed CEO succession plan effective April 27, 2026, with Alex Alcala assuming the role of President and Chief Executive Officer, succeeding Max Mitchell who transitioned to Executive Chairman. Alcala brings 13 years of experience at Crane, having contributed to strategy, portfolio strengthening, and execution. The transition was described as seamless, with the company positioned for future growth under Alcala's leadership.

• ·Company founded in 1855.
• ·Focused on aerospace, defense, space, and process industry end markets.

27-04-2026

Health Catalyst, Inc. announced that Linda Llewelyn will cease serving as Chief People Officer effective June 1, 2026, due to the elimination of the role amid a workforce reduction, transitioning instead to a senior advisor role through September 1, 2026, with separation benefits under the Executive Severance Plan. As part of Project Nexus strategic initiative, the Board authorized a global workforce reduction of approximately 9% plus elimination of about 100 open budgeted headcount positions across the US and India to simplify the organizational structure and reduce costs. Further details will be provided in the upcoming Quarterly Report on Form 10-Q.

• ·Workforce reduction authorized by Board on April 24, 2026.
• ·Separation agreement with Ms. Llewelyn expected to include general release of claims.
• ·Executive Severance Plan benefits summarized in Definitive Proxy Statement filed May 19, 2025.

27-04-2026

Tompkins Financial Corporation announced the appointment of Phillip M. Quintana as President of Tompkins Community Bank and Executive Vice President of the Company, effective April 27, 2026, succeeding John M. McKenna who is stepping down after 17 years of service due to personal health considerations. Mr. Quintana had been appointed President-Elect of the Bank on March 16, 2026. This leadership transition at the subsidiary bank was disclosed in an 8-K filing under Item 5.02.

• ·Common Stock, $0.10 par value, trades under symbol TMP on NYSE American, LLC.
• ·Entity Central Index Key: 0001005817
• ·Fiscal year end: December 31

27-04-2026

Plumas Bancorp appointed Kelsey Cassinelli as Principal Accounting Officer on April 27, 2026, replacing Richard Belstock who continues as Principal Financial Officer. Ms. Cassinelli, previously a Senior Audit Manager at KPMG US LLP since April 2024, joined the company after employment there since 2016. No family relationships or reportable related party transactions exist with Ms. Cassinelli.

• ·Ms. Cassinelli is age 32.
• ·No family relationships between Ms. Cassinelli and any director or other executive officer of the Company.
• ·No transactions between Ms. Cassinelli or her immediate family and the Company or subsidiaries reportable as related party transactions.

27-04-2026

On April 22, 2026, Yunhong Green CTI Ltd. (YHGJ) appointed existing board member Fred H.F. Chak as Chairman of the Board, effective April 27, 2026, succeeding Gerald D. Roberts Jr., who had served as interim Chairman since February 17, 2026. Mr. Roberts will continue serving as a director. This is a routine board leadership transition with no other changes noted.

• ·Company address: 22160 N. Pepper Road, Lake Barrington, IL 60010
• ·Telephone: (847) 382-1000
• ·Trading symbol: YHGJ on Nasdaq Capital Market